Advisor Group’s Co-Diagnostics CODX Stock Holding History

Advisor Group’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Hold	100	–	–	﹤0.01%	4829
2019 Q3	$3K	Hold	100	–	–	﹤0.01%	4819
2019 Q2	$2K	Hold	100	–	–	﹤0.01%	4953
2019 Q1	$3K	Hold	100	–	–	﹤0.01%	4827
2018 Q4	$4K	Buy	+100	New	+$6.53K	﹤0.01%	4598

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Advisor Group's CODX Position: Q4 2019 in Review

Advisor Group held its Co-Diagnostics (CODX) position steady in Q4 2019 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4829.

Advisor Group first reported a position in CODX in Q4 2018 and has held it in 5 quarters since. The position peaked at $4K in Q4 2018. 10 funds tracked by Wall St. Rank hold CODX as of Q4 2019.

Advisor Group held 100 shares of Co-Diagnostics worth $3K as of Q4 2019.
Advisor Group left its Co-Diagnostics share count unchanged in Q4 2019.
Co-Diagnostics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4829 holding.
Advisor Group first reported a position in Co-Diagnostics in Q4 2018 and has held it in 5 quarters since.
Advisor Group's Co-Diagnostics position peaked at $4K in Q4 2018.
10 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.